As per Intent Market Research, the Animal Biotechnology Market was valued at USD 29.8 billion in 2023 and will surpass USD 57.1 billion by 2030; growing at a CAGR of 9.7% during 2024 - 2030.
The animal biotechnology market encompasses a wide range of innovative technologies that utilize biological principles to improve livestock productivity, health, and disease resistance. It integrates cutting-edge methods such as genetic engineering, cloning, and advanced diagnostics to enhance the quality and efficiency of animal production. Additionally, biotechnology applications extend beyond agriculture to healthcare and environmental sectors, reflecting its vast potential across diverse industries. As global demand for food production and animal health management continues to rise, animal biotechnology is expected to play an increasingly pivotal role in shaping the future of agriculture, healthcare, and environmental sustainability.
Genetic engineering dominates the animal biotechnology market due to its transformative impact on livestock productivity and health. By utilizing precise genetic modifications, genetic engineering enables the creation of animals with superior traits, such as disease resistance, improved growth rates, and higher milk or egg production. The technology’s widespread application in livestock breeding, such as cattle, poultry, and swine, is driving its large market share. These advancements help farmers optimize resources, increase yields, and reduce disease-related losses, all while contributing to more sustainable farming practices.
The growth of genetic engineering is propelled by its broad acceptance in agriculture and animal husbandry. The ongoing research into genetically modified animals that are resistant to diseases such as Bovine Spongiform Encephalopathy (BSE) or avian influenza has further solidified genetic engineering’s importance. The increased adoption of genetically modified organisms (GMOs) in agriculture is expected to fuel the market for genetic engineering in the coming years.
The livestock segment holds the largest share of the animal biotechnology market, driven by the high global demand for meat, milk, and other animal products. Livestock farming, particularly cattle, poultry, and swine, is central to food production systems worldwide. Biotechnology innovations in this segment focus on improving animal health, increasing disease resistance, and optimizing breeding practices to meet the growing global population's food security needs. Through biotechnology, farmers can enhance livestock productivity by improving feed efficiency and reproductive performance, thus increasing overall production.
Livestock farming represents a critical component of agricultural economies, especially in regions like North America, Europe, and parts of Asia. As consumer demand for animal-based protein increases, the application of biotechnology in livestock is set to expand further, fostering increased market growth in both developed and emerging markets.
Among the various applications of animal biotechnology, agricultural biotechnology is the fastest growing. This segment integrates biotechnological advances in animal health to improve food production, particularly in terms of livestock and crop productivity. By enhancing animal genetics and health, agricultural biotechnology contributes to more efficient food production systems, ensuring greater sustainability and higher yields. Key innovations, such as genetically modified animals and the use of probiotics and enzymes in animal feed, are making a significant impact on global agricultural productivity.
The agricultural biotechnology market is expanding rapidly as governments and private stakeholders focus on improving food security. The need to feed a growing global population, combined with the pressure of climate change on agricultural systems, makes this sector increasingly important. The adoption of biotechnological solutions to optimize animal and crop production is expected to drive growth in this segment in the coming years.
CRISPR technology is the fastest growing segment in animal biotechnology, owing to its precision, efficiency, and cost-effectiveness. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) allows for targeted editing of animal genomes, enabling the development of animals with specific desired traits, such as disease resistance or enhanced productivity. Its ability to modify genetic material with high accuracy and minimal errors makes it a preferred method in biotechnology research. The technology is revolutionizing the way animals are bred and managed, especially in livestock and companion animal care.
The growing interest in CRISPR is also driven by its potential applications in genetic disease prevention and improving overall animal health. As CRISPR technology continues to evolve, it is expected to become even more integral to the animal biotechnology market, fueling further growth in the coming years.
The agriculture end-user industry is the largest in the animal biotechnology market, primarily due to the high adoption of biotechnology in farming practices. Animal biotechnology in agriculture involves improving livestock health, enhancing disease resistance, and increasing production efficiency. Biotechnological tools, such as genetic engineering and cloning, are used to breed superior animals that can adapt to varying environmental conditions and deliver higher outputs in terms of milk, meat, or wool. With the growing global demand for food, particularly animal-based products, agriculture is increasingly reliant on biotechnology to meet this need sustainably.
The agricultural sector's reliance on biotechnology is particularly strong in countries with large-scale livestock operations, such as the United States, Brazil, and China. As the industry continues to embrace technology-driven solutions, the agricultural sector will remain a key driver of the overall animal biotechnology market.
North America is the largest region in the animal biotechnology market, owing to its advanced research and development infrastructure, strong regulatory framework, and large-scale agricultural production. The United States, in particular, has been at the forefront of biotechnology innovations, with significant investments in animal health, agricultural biotechnology, and genetic engineering. The region’s well-established agricultural industry, combined with its emphasis on cutting-edge scientific advancements, makes it a hub for animal biotechnology applications. Furthermore, regulatory agencies such as the FDA and USDA support the development of biotechnology, ensuring the safe and ethical use of animal biotechnologies.
As North America continues to lead in research and development, it is expected to maintain its dominant position in the market. The region’s strong adoption of genetic modification and other biotechnological innovations in agriculture and healthcare ensures ongoing growth and opportunities in the animal biotechnology sector.
The animal biotechnology market is highly competitive, with several key players leading the innovation and development of biotechnological solutions for animal health and agriculture. Companies like Zoetis Inc., Merck Animal Health, Bayer AG, and Elanco Animal Health are major contributors to the market, investing heavily in R&D to develop advanced biotechnologies such as gene editing, CRISPR, and genetic modification tools. These companies are also expanding their portfolios through strategic mergers, acquisitions, and partnerships with research institutions and biotech firms.
The competitive landscape is characterized by ongoing innovation, as companies seek to address the growing need for sustainable and efficient animal farming practices. Additionally, there is a focus on regulatory compliance, as governments across various regions tighten regulations concerning genetic modifications and animal health products. As the market continues to grow, competition will intensify, with new players emerging alongside established firms.
Report Scope:
Report Features |
Description |
Market Size (2023) |
USD 29.8 Billion |
Forecasted Value (2030) |
USD 57.1 Billion |
CAGR (2024 – 2030) |
9.7% |
Base Year for Estimation |
2023 |
Historic Year |
2022 |
Forecast Period |
2024 – 2030 |
Report Coverage |
Market Forecast, Market Dynamics, Competitive Landscape, Recent Developments |
Segments Covered |
Animal Biotechnology Market By Product Type (Genetic Engineering, Breeding Technologies, Cloning, Diagnostics), By Animal Type (Livestock, Companion Animals, Aquatic Animals), By Application (Agricultural Biotechnology, Healthcare Biotechnology, Food & Agriculture Production, Environmental Biotechnology, Forensic Biotechnology), By Technology (CRISPR Technology, RNA Interference Technology, Recombinant DNA Technology, Gene Editing), By End-User Industry (Agriculture, Healthcare, Environmental, Food & Beverages, Pharmaceuticals) |
Regional Analysis |
North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, Australia, India, and Rest of Asia-Pacific), Latin America (Brazil, Argentina, and Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Rest of Middle East & Africa) |
Major Companies |
Zoetis Inc., Merck Animal Health, Bayer AG, Elanco Animal Health, Boehringer Ingelheim, Genus PLC, IDEXX Laboratories, Thermo Fisher Scientific, Neogen Corporation, Virbac SA, Agilent Technologies, Regeneron Pharmaceuticals, AbbVie Inc., Charles River Laboratories, AgBio Inc. |
Customization Scope |
Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements |
1. Introduction |
1.1. Market Definition |
1.2. Scope of the Study |
1.3. Research Assumptions |
1.4. Study Limitations |
2. Research Methodology |
2.1. Research Approach |
2.1.1. Top-Down Method |
2.1.2. Bottom-Up Method |
2.1.3. Factor Impact Analysis |
2.2. Insights & Data Collection Process |
2.2.1. Secondary Research |
2.2.2. Primary Research |
2.3. Data Mining Process |
2.3.1. Data Analysis |
2.3.2. Data Validation and Revalidation |
2.3.3. Data Triangulation |
3. Executive Summary |
3.1. Major Markets & Segments |
3.2. Highest Growing Regions and Respective Countries |
3.3. Impact of Growth Drivers & Inhibitors |
3.4. Regulatory Overview by Country |
4. Animal Biotechnology Market, by Product Type (Market Size & Forecast: USD Million, 2022 – 2030) |
4.1. Genetic Engineering |
4.2. Breeding Technologies |
4.3. Cloning |
4.4. Diagnostics |
4.5. Others |
5. Animal Biotechnology Market, by Animal Type (Market Size & Forecast: USD Million, 2022 – 2030) |
5.1. Livestock |
5.2. Companion Animals |
5.3. Aquatic Animals |
5.4. Others |
6. Animal Biotechnology Market, by Application (Market Size & Forecast: USD Million, 2022 – 2030) |
6.1. Agricultural Biotechnology |
6.2. Healthcare Biotechnology |
6.3. Food & Agriculture Production |
6.4. Environmental Biotechnology |
6.5. Forensic Biotechnology |
7. Animal Biotechnology Market, by Technology (Market Size & Forecast: USD Million, 2022 – 2030) |
7.1. CRISPR Technology |
7.2. RNA Interference Technology |
7.3. Recombinant DNA Technology |
7.4. Gene Editing |
7.5. Others |
8. Animal Biotechnology Market, by End-User Industry (Market Size & Forecast: USD Million, 2022 – 2030) |
8.1. Agriculture |
8.2. Healthcare |
8.3. Environmental |
8.4. Food & Beverages |
8.5. Pharmaceuticals |
9. Regional Analysis (Market Size & Forecast: USD Million, 2022 – 2030) |
9.1. Regional Overview |
9.2. North America |
9.2.1. Regional Trends & Growth Drivers |
9.2.2. Barriers & Challenges |
9.2.3. Opportunities |
9.2.4. Factor Impact Analysis |
9.2.5. Technology Trends |
9.2.6. North America Animal Biotechnology Market, by Product Type |
9.2.7. North America Animal Biotechnology Market, by Animal Type |
9.2.8. North America Animal Biotechnology Market, by Application |
9.2.9. North America Animal Biotechnology Market, by Technology |
9.2.10. North America Animal Biotechnology Market, by End-User Industry |
9.2.11. By Country |
9.2.11.1. US |
9.2.11.1.1. US Animal Biotechnology Market, by Product Type |
9.2.11.1.2. US Animal Biotechnology Market, by Animal Type |
9.2.11.1.3. US Animal Biotechnology Market, by Application |
9.2.11.1.4. US Animal Biotechnology Market, by Technology |
9.2.11.1.5. US Animal Biotechnology Market, by End-User Industry |
9.2.11.2. Canada |
9.2.11.3. Mexico |
*Similar segmentation will be provided for each region and country |
9.3. Europe |
9.4. Asia-Pacific |
9.5. Latin America |
9.6. Middle East & Africa |
10. Competitive Landscape |
10.1. Overview of the Key Players |
10.2. Competitive Ecosystem |
10.2.1. Level of Fragmentation |
10.2.2. Market Consolidation |
10.2.3. Product Innovation |
10.3. Company Share Analysis |
10.4. Company Benchmarking Matrix |
10.4.1. Strategic Overview |
10.4.2. Product Innovations |
10.5. Start-up Ecosystem |
10.6. Strategic Competitive Insights/ Customer Imperatives |
10.7. ESG Matrix/ Sustainability Matrix |
10.8. Manufacturing Network |
10.8.1. Locations |
10.8.2. Supply Chain and Logistics |
10.8.3. Product Flexibility/Customization |
10.8.4. Digital Transformation and Connectivity |
10.8.5. Environmental and Regulatory Compliance |
10.9. Technology Readiness Level Matrix |
10.10. Technology Maturity Curve |
10.11. Buying Criteria |
11. Company Profiles |
11.1. Zoetis Inc. |
11.1.1. Company Overview |
11.1.2. Company Financials |
11.1.3. Product/Service Portfolio |
11.1.4. Recent Developments |
11.1.5. IMR Analysis |
*Similar information will be provided for other companies |
11.2. Merck Animal Health |
11.3. Bayer AG |
11.4. Elanco Animal Health |
11.5. Boehringer Ingelheim |
11.6. Genus PLC |
11.7. IDEXX Laboratories |
11.8. Thermo Fisher Scientific |
11.9. Neogen Corporation |
11.10. Virbac SA |
11.11. Agilent Technologies |
11.12. Regeneron Pharmaceuticals |
11.13. AbbVie Inc. |
11.14. Charles River Laboratories |
11.15. AgBio Inc. |
12. Appendix |
A comprehensive market research approach was employed to gather and analyze data on the Animal Biotechnology Market. In the process, the analysis was also done to analyze the parent market and relevant adjacencies to measure the impact of them on the Animal Biotechnology Market. The research methodology encompassed both secondary and primary research techniques, ensuring the accuracy and credibility of the findings.
Secondary research involved a thorough review of pertinent industry reports, journals, articles, and publications. Additionally, annual reports, press releases, and investor presentations of industry players were scrutinized to gain insights into their market positioning and strategies.
Primary research involved conducting in-depth interviews with industry experts, stakeholders, and market participants across the E-Waste Management ecosystem. The primary research objectives included:
A combination of top-down and bottom-up approaches was utilized to analyze the overall size of the Animal Biotechnology Market. These methods were also employed to assess the size of various subsegments within the market. The market size assessment methodology encompassed the following steps:
To ensure the accuracy and reliability of the market size, data triangulation was implemented. This involved cross-referencing data from various sources, including demand and supply side factors, market trends, and expert opinions. Additionally, top-down and bottom-up approaches were employed to validate the market size assessment.